Daniel Spratt, MD
Radiation Oncology · Cleveland, OHNPI 1780905901
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $56,931 of the $85,666 with a category attached, or 66.5%. It is spread thinly across 20 manufacturers, the largest accounting for just 15.8%. Reporting peaked in 2024 at $32,465 and has fallen 70.8% since, to $9,495 in 2025. Among radiation oncology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $1206.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$14K
- Pfizer$12K
- Bayer$9K
- Janssen Global Services, LLC$9K
- Boston Scientific$7K
- Myovant Sciences Inc.$6K
- plus $28K from 14 others
Across 41 payments — averaging $18,337 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$603K
- Sumitomo Pharma America, Inc.$145K
- Pfizer$3K
What the payments were for
- Consulting fees$56,93166%
- Speaking & faculty fees$24,92029%
- Travel & lodging$1,5382%
- Food & beverage$2,2763%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 6 | $13,555 |
| Pfizer | 7 | $12,360 |
| Bayer | 10 | $9,444 |
| Janssen Global Services, LLC | 3 | $9,438 |
| Boston Scientific | 9 | $6,673 |
| Myovant Sciences Inc. | 2 | $5,820 |
| Novartis | 3 | $4,908 |
| Astellas Pharma Global Development | 3 | $4,568 |
| Advanced Accelerator Applications | 2 | $3,480 |
| Janssen Scientific Affairs, LLC | 4 | $3,358 |
| GSK | 3 | $2,564 |
| Photocure Inc | 2 | $2,298 |
| Johnson & Johnson | 2 | $1,828 |
| Blue Earth Diagnostics | 1 | $1,700 |
| AstraZeneca | 1 | $1,510 |
| Sanofi | 6 | $717 |
| GT Medical Technologies, Inc | 1 | $675 |
| Nucletron Operations B.v. | 2 | $535 |
| Mevion_medical_systems_inc | 1 | $160 |
| Siemens Medical Solutions USA, Inc. | 3 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTANDI$16,767
- Erleada$14,465
- Xofigo$9,173
- ORGOVYX$6,040
- SpaceOAR System$3,400
- SPACEOAR VUE$2,682
- Cysview$2,250
- Axumin$1,700
- GammaTile$675
- NO PRODUCT DISCUSSED$674
- FLEXITRON HDR$535
- Esteya$535
- MICROSELECTRON DIGITAL$535
- SpaceOAR VUE System - 10mL$447
- TALZENNA$220
- PTS250$160
How this compares
$85,666 in reported general payments places this provider in the 95th percentile of 255 radiation oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Cleveland
- Shlomo KoyfmanCleveland$72K
- Gerald SokolCleveland$61K
- Rahul TendulkarCleveland$26K
- Angela Yuanyuan JiaCleveland$20K
- Samuel ChaoCleveland$18K
- John SuhCleveland$16K
- Shauna CampbellCleveland$12K
- Haley PerlowCleveland$7K
- Sudha AmarnathCleveland$7K
- Ryan FecteauCleveland$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.